Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6248-6255, Vol. 69, No. 10
Skirball Institute and Department of Microbiology, New York
University School of Medicine, New York, New York
10016,1 and Center for Microbial
Pathogenesis and Department of Medicine, University of Connecticut
Health Center, Farmington, Connecticut 060302
Received 6 April 2001/Returned for modification 6 June
2001/Accepted 9 July 2001
Shigella spp. cause dysentery, a severe form of
bloody diarrhea. Apoptosis, or programmed cell death,
is induced during Shigella infections and has
been proposed to be a key event in the pathogenesis of dysentery. Here,
we describe a novel cytotoxic activity in the sterile-culture
supernatants of Shigella flexneri. An identical activity
was identified in purified S. flexneri endotoxin,
defined here as a mixture of lipopolysaccharide (LPS) and
endotoxin-associated proteins (EP). Separation of endotoxin into EP and
LPS revealed the activity to partition exclusively to the EP fraction.
Biochemical characterization of S. flexneri EP and
culture supernatants, including enzymatic deactivation,
reverse-phase high-pressure liquid chromatography analysis, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, and a Toll-like
receptor-2 (TLR2) activation assay, indicates that the cytotoxic
component is a mixture of bacterial lipoproteins (BLP). We show that
biologically active BLP are liberated into culture supernatants of
actively growing S. flexneri. In addition, our data
indicate that BLP, and not LPS, are the component of endotoxin of
gram-negative organisms responsible for activating TLR2. The activation
of apoptosis by BLP shed from S. flexneri is
discussed as a novel aspect of the interaction of bacteria with the host.
The gram-negative bacterium
Shigella is the etiological agent of dysentery, a severe
form of bloody diarrhea that causes approximately 1.1 million deaths
annually (13). Dysentery is characterized by fever,
painful abdominal cramps, and frequent stools containing blood and
mucus. These symptoms result from invasion of the colonic mucosa by
Shigella and the intense inflammatory response of the host
to the bacteria (16).
The initial site of tissue invasion by Shigella occurs at
epithelia overlying lymphoid follicles of the gut-associated lymphatic tissue (GALT) (22). After invasion, the bacteria localize
exclusively to the follicular dome, within and directly below the
epithelial layer (23). Shigella flexneri has
been shown to induce apoptosis in macrophages in vitro, through
a pathway dependent on the secreted virulence protein called invasion
plasmid antigen B (IpaB). To kill macrophages, IpaB must be released
directly into the cytoplasm of S. flexneri-infected
cells (6). In vivo, however, the distribution of cell
death induced by S. flexneri in the lymphoid
follicle is not restricted to the location of the bacteria
(40). These observations suggest that a second diffusible
effector of cell death is generated during S. flexneri
infections. We proposed that this toxin is produced either by
S. flexneri-infected cells or by the bacteria themselves.
Here, using a macrophage cytotoxicity assay, we identify a novel
cytotoxic activity in the sterile-culture supernatants of S. flexneri. Biochemical characterization of the
cytotoxic activity, including enzymatic deactivation, high-pressure
liquid chromatography (HPLC), sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and a Toll-like
receptor-2 (TLR2) activation assay, indicates that it is a mixture of
bacterial lipoproteins (BLP). BLP are made by all bacteria and are
characterized by a unique N-terminal lipo-amino acid,
N-acyl-S-diacylglyceryl cysteine
(34). These molecules are capable of activating numerous
host immunologic responses, as well as cell death. These cellular
responses are mediated by the cell surface receptor, TLR2 (1,
5). BLP are localized only to the periplasmic leaflets of the
inner and outer membranes in gram-negative bacteria (34).
Given this topology, it is not clear whether BLP are available to
engage TLR2 on host cells. Our results demonstrate that biologically
active BLP are liberated from culture supernatants of S. flexneri.
Reagents and cell culture.
Synthetic lipopeptides
Pam3CysSerLys4 (sBLP) and
47L, the negative-control compounds Pam3Cys and
47, and Escherichia coli murein lipoprotein have been
described (1, 25). Lipopeptide stocks were made at 1 mg/ml
in endotoxin-free water with 0.05% human serum albumin (Grifols,
Miami, Fla.). Silver staining and colloidal-gold staining were
performed with the Bio-Rad Silver Stain kit and Bio-Rad Colloidal Gold
Total Protein Stain (Bio-Rad Laboratories, Hercules, Calif.). All other
reagents were from Sigma.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6248-6255.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Release of Toll-Like Receptor-2-Activating Bacterial
Lipoproteins in Shigella flexneri Culture
Supernatants
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Preparation of culture supernatants of S.
flexneri and S. flexneri-infected
macrophages
Unless otherwise indicated, bacteria
were grown in tryptic soy broth at 37°C with agitation. An overnight
culture of S. flexneri (serotype V
[37] or serotype 1A [ATCC 9199]) was subcultured at a
dilution of 1:100 and grown for 2 h. The bacteria were collected by centrifugation, washed with serum-free RPMI 1640, and suspended to
the appropriate concentration in serum-free RPMI 1640. J774 cells were
infected at a multiplicity of infection of 100 as described previously (38) and incubated at 37°C for 2 to 3 h.
The culture supernatants were collected, sterile filtered
(0.2-µm-pore-size filter), and concentrated approximately
20-fold using a 10-kDa Centriprep concentrator (Amicon, Beverly,
Mass.). Supernatants were stored at
20°C until used in
cytotoxicity assays. Culture supernatants of bacteria only and
uninfected macrophages were prepared similarly in parallel.
Cytotoxicity assays. Cytotoxicity assays were performed essentially as described previously (1). Cells were plated in triplicate wells of a 96-well plate and allowed to adhere for 6 h, and then the components to be tested were added. Between 1 × 104 and 2.5 × 104 cells were used per well. Cytotoxicity was determined 3 to 6 h after the addition of test components by a lactate dehydrogenase (LDH) release assay (Cytotox96 kit; Promega, Madison, Wis.). Phorbol myristate acetate-stimulated THP-1 cells or, where indicated, cycloheximide-treated THP-1 cells were used as described previously (1). Cell culture supernatants were diluted to a final concentration of 3× with serum-free tissue culture media.
Preparation of TCA-endotoxin, EP, and PW-LPS. The preparation of trichloroacetic acid (TCA)-endotoxin was performed as previously described (27). The preparation of endotoxin-associated proteins (EP) and phenol-water (PW)-lipopolysaccharide (LPS) from TCA-endotoxin was performed as previously described (28).
Preparation of phenol extracts of bacterial supernatants. Forty milliliters of an overnight culture of S. flexneri type 1A was added to 4 liters of tryptic soy broth and grown to an optical density at 600 nm of 0.8. The bacteria were centrifuged, washed with serum-free RPMI 1640, resuspended in 5,500 ml of serum-free RPMI 1640, and grown for 2.5 h. The bacteria were removed by centrifugation, and the supernatant was sterile filtered and concentrated to 5.5 ml using an Amicon Series 8400 Stirred Cell Concentrator and a 10-kDa cutoff ultrafiltration membrane (Millipore, Bedford, Mass.). The concentrated supernatant was extracted with hot phenol as described above for the preparation of EP and PW-LPS from TCA-endotoxin. Ethanol precipitates of the phenol and aqueous phases were resuspended in 5.5 ml of endotoxin-free 1× phosphate-buffered saline (PBS).
RP-HPLC and mass spectrometry. Reverse-phase (RP)-HPLC was performed on a Beckman HPLC using a C4 or diphenyl RP-HPLC column (Vydac, Hesperia, Calif.). All solvents were HPLC grade from Fisher Chemicals and were degassed for 10 min under vacuum prior to use. HPLC conditions are indicated in the legend to Fig. 4. Fractions were tested for cytotoxic activity by serial dilution directly into tissue culture media or by lyophilizing the fraction, resuspending in 1× PBS and diluting serially into tissue culture media. Both methods yielded similar results. Samples for mass spectrometry were lyophilized, resuspended in 80% acetonitrile (ACN)-0.1% formic acid, and analyzed by electrospray-ionization mass spectrometry at the William M. Keck Foundation Biotechnology Resource Laboratory, Yale University.
Measurement of reactive oxygen species production and NF-
B
activation.
Measurement of reactive oxygen species production by
peripheral blood leukocytes by lucigenin-enhanced chemiluminescence and the NF-
B luciferase reporter gene assay were performed as previously described (1) or as indicated in the figure legends.
Extraction of cytotoxic activity from Tris-Tricine gels. Five hundred microliters of a 10-mg/ml solution of S. flexneri EP was incubated with 0.2 U of proteinase K (PK) agarose beads or an equivalent amount of uncoupled agarose beads as a control for 4 h at 37°C. The beads were removed by centrifugation, and the supernatant was collected, mixed with 2 volumes of Tris-Tricine SDS-PAGE sample buffer (Bio-Rad), and heated at 95°C for 5 min. Fifty microliters of each was loaded on nonadjacent lanes of a 10-well 16.5% Tris-Tricine Ready Gel (Bio-Rad). An additional gel was loaded identically, except that a peptide molecular weight (MW) marker (Bio-Rad) was included, and run in parallel. Individual lanes were isolated and cut into 11 5-mm sections. Individual gel sections were extracted with 200 µl of 25 mM octyl glucoside (Anatrace, Maumee, Ohio) for 5 min at 100°C as previously described (19). Supernatants were collected and tested for cytotoxic activity. The second gel containing the peptide MW marker was silver stained.
Purification of the cytotoxic activity from S. flexneri EP by SDS-PAGE and RP-HPLC for the TLR2 stimulation assay. A total of 2.5 mg of S. flexneri EP was mixed with 500 µl of Tris-Tricine SDS-PAGE sample buffer, heated for 5 min at 95°C, and resolved on a Bio-Rad 16.5% Tris-Tricine Preparative Ready Gel. The portion of the gel between 1.5 and 3 cm from the gel front was collected, minced with a clean razor blade, and extracted with 4 ml of 25 mM octyl glucoside for 10 min at 100°C. One milliliter of this extract was mixed with 4 ml of 62.5% ACN-0.125% trifluoroacetic acid and loaded onto a diphenyl RP-HPLC column (Vydac) and resolved under the following conditions. Buffer A consisted of 52.4% ACN and 0.1% TFA, buffer B consisted of 95% ACN and 0.1% TFA, and the flow rate was 1 ml/min. The gradient was as follows: 0 to 5 min, 100% buffer A; 5 to 15 min, 0 to 100% buffer B (linear gradient); 15 to 17 min, 100% buffer B; 17 to 19 min, 100 to 0% buffer B. Under these conditions, the octyl glucoside eluted in the flowthrough. One-minute fractions (1 ml each) were collected and assayed for cytotoxic activity on THP-1 cells. The activity completely eluted between min 8 and 9. Control gels loaded with an equal amount of Tris-Tricine SDS-PAGE sample buffer did not produce cytotoxic activity in this HPLC fraction.
| |
RESULTS |
|---|
|
|
|---|
The culture supernatants of S. flexneri contain
a cytotoxic activity.
As indicated in the introduction,
S. flexneri induces a widespread pattern of cell death
in vivo that does not completely colocalize with the distribution of
intratissular bacteria (40). We proposed that a diffusible
cytotoxin is active in S. flexneri infections. Since
S. flexneri encounters resident tissue macrophages early in the pathogenesis of dysentery (39), we
hypothesized that the diffusible, apoptosis-inducing factor may
be produced by S. flexneri-infected macrophages.
Alternatively, the cytotoxin may be produced by the bacteria
themselves. Supernatant preparations from S. flexneri type 1A-infected macrophages and S. flexneri type 1A alone were found to contain similar levels of
cytotoxic activity as assayed on phorbol myristate acetate-stimulated
THP-1 cells (Fig. 1A). The culture
supernatants of uninfected macrophages were not cytotoxic.
Supernatant preparations from macrophages infected with either a
wild-type S. flexneri type V strain (M90T) or an
isogenic avirulent derivative cured of the Shigella
virulence plasmid (BS176) (37) were equally
cytotoxic (data not shown), indicating that production of the cytotoxic
activity is not dependent on the Shigella virulence plasmid
(24). The cytotoxic activity was stable during proteinase
K treatment and boiling for 10 min and did not pass through a
10,000-MW-cutoff filter, indicating that it is greater than 10 kDa or
aggregated (data not shown).
|
TCA-endotoxin, but not PW-LPS, is cytotoxic to THP-1 cells. Endotoxin of gram-negative organisms contains LPS, an outer membrane glycolipid with potent immunostimulatory properties, proteins, and phospholipids (8), and in composition resembles the bacterial outer membrane (11, 21). The proteins in endotoxin, EP, are a mixture of porins, BLP, and other outer membrane proteins (7). LPS can be isolated from smooth gram-negative enteric bacteria by either a TCA precipitation method, originally outlined by Boivin (27) (TCA-endotoxin), or a hot-phenol extraction method, described by Westphal and Jann (32) (PW-LPS). In the Boivin procedure, precipitation of bacteria with TCA releases complexes of LPS and EP that can be isolated by precipitation with cold ethanol. For clarity, we call this heterogeneous preparation TCA-endotoxin. In the Westphal hot-phenol extraction method, LPS partitions to the aqueous layer due to the hydrophilic nature of the core and O-antigen carbohydrate side chains. EP, however, are extracted into the phenol phase. Therefore, LPS isolated by the Westphal phenol extraction method is purer than preparations isolated by the Boivin procedure.
Commercial preparations of S. flexneri type 1A TCA-endotoxin, but not PW-LPS, induced cell death in THP-1 cells within 4 h of exposure (Fig. 1B). However, as little as 625 pg of PW-LPS per ml induced reactive oxygen species production in human peripheral blood leukocytes (data not shown), indicating that this preparation has potent biologic activity. PW-LPS was also capable of stimulating tumor necrosis factor alpha and pro-interleukin-1
production in murine
peritoneal macrophages (data not shown).
The cytotoxic activity of TCA-endotoxin partitions to the organic
phase in a hot-phenol extraction.
TCA-endotoxin was prepared in
our laboratory from S. flexneri type 1A by the Boivin
procedure and fractionated into PW-LPS and EP by a Westphal
hot-phenol extraction (28). Five micrograms of
TCA-endotoxin per milliliter induced an appreciable cytotoxic response.
However, only 50 ng of EP/ml was necessary to kill THP-1 cells (Fig.
2A), indicating that the cytotoxic
activity is enriched in the EP fraction of TCA-endotoxin. In contrast,
doses as high as 50 µg of PW-LPS per ml were noncytotoxic.
|
BLP are cytotoxic to THP-1 cells. BLP are produced by all bacteria, including gram-negative and gram-positive bacteria, as well as spirochetes and Mycoplasma spp. (8). BLP are characterized by a unique, N-terminal lipo-amino acid, N-acyl-S-diacylglyceryl cysteine (Acyl3Cys) (34), which activates host defense mechanisms (12, 26). It has recently been shown that BLP also induce apoptosis through TLR2 (1, 2). The immunomodulatory properties of BLP are stable during heat and protease treatment (20, 31, 33), since the N-terminal lipo-amino acid is unaffected by either treatment. In addition, BLP contain proteinaceous and lipid components and would be expected to be soluble in phenol. Therefore, it was hypothesized that BLP were the cytotoxic factors in S. flexneri EP and culture supernatants.
Synthetic BLP analogs consisting of a palmitylated version of N-acyl-S-diacylglyceryl cysteine (Pam3Cys) and a few C-terminal amino acids can mimic the immunomodulatory effects of BLP (12). Interestingly, the lipo-amino acid Pam3Cys alone is insufficient for immunostimulation (1). The synthetic lipopeptide 47L, which corresponds to the N terminus of the Treponema pallidum 47-kDa lipoprotein (25), and Pam3CysSerLys4 (sBLP) both induced cytotoxicity in THP-1 cells (Fig. 3). Pam3Cys alone or an unlipidated 47L peptide did not induce cytotoxicity (Fig. 3).
|
RP-HPLC analysis of sBLP, EP, and the phenol extracts of
S. flexneri culture supernatants.
Phenol
extracts of S. flexneri culture supernatants and a
preparation of S. flexneri EP were loaded on a RP-HPLC
column and resolved with a linear gradient of increasing ACN
concentration. The cytotoxic activity in both S. flexneri culture supernatants and S. flexneri EP
eluted at a high concentration of organic solvent (between 85 and 95%
ACN) (Fig. 4A and B). This indicates that the toxin is extremely lipophilic. Equivalent fractions collected from
a blank HPLC run did not contain cytotoxic activity (data not shown).
|
The cytotoxic activity in EP contains lipid and protein
components.
sBLP and S. flexneri EP were treated
with agarose beads coupled to a triacylglycerol lipase and tested for
the ability to kill THP-1 cells. After treatment with the lipase beads,
the EP and sBLP solutions were 100-fold less active in the cell death assay than control treated samples (Fig.
5A and B). This finding supports the
hypothesis that the cytotoxic activity in EP is carried out by BLP.
Lipase beads similarly inhibited the cytotoxic activity in phenol
extracts of bacterial supernatants (data not shown).
|
An RP-HPLC fraction containing the cytotoxic activity in EP
activates TLR2 signaling.
BLP activate apoptosis and
NF-
B-dependent transcription through TLR2 (1, 5, 9,
14). NF-
B is a transcriptional regulator of numerous host
defense genes (3). We reasoned that if the cytotoxic
activity elements purified from S. flexneri
TCA-endotoxin are BLP, then they should also stimulate TLR2 signaling.
B-dependent, E-selectin promoter (36). Stimulation of these cells with as little as 100 ng of S. flexneri
type 1A TCA-endotoxin per ml activated the reporter gene (Fig
6A). Similarly to the cytotoxic activity,
the TLR2 stimulatory activity in TCA-endotoxin was recovered in the EP
component. Moreover, PW-LPS was inactive in this assay.
|
B-dependent luciferase reporter gene. An
HPLC fraction containing the cytotoxic activity in EP, but not an
equivalent fraction from a blank HPLC run, activated the reporter gene
(Fig. 6B). sBLP was used as a positive control and stimulated
NF-
B-dependent transcription. Approximately 100 pg of sBLP per ml
induced the reporter gene equivalently to a 1:2,000 dilution of the
active HPLC fraction. Signaling was dependent on the expression of
TLR2, as parental 293 cells, or cells stably transfected with CD14 only
(36), did not respond to the active HPLC fraction (Fig.
6C). Since BLP, but not LPS, activate TLR2 signaling, these data
support the proposition that the cytotoxic component in S. flexneri EP consists of BLP.
| |
DISCUSSION |
|---|
|
|
|---|
In vivo, Shigella induces a pattern of apoptosis that does not colocalize with intratissular bacteria (23, 40). These data suggested that a diffusible toxin might be involved during infections. Here, we identify a cytotoxic activity in the sterile culture supernatants of S. flexneri. The following data support the proposition that the cytotoxic factors in S. flexneri EP and bacterial culture supernatants are BLP: (i) a triacylglycerol lipase abolishes the cytotoxic activity (Fig. 5A), (ii) the factors contain a protein component that is not essential for biologic activity (Fig. 5C), (iii) the cytotoxic activity displays an elution profile on an RP-HPLC column similar to that of a synthetic bacterial lipopeptide (Fig. 4), (iv) an RP-HPLC fraction containing the cytotoxic activity stimulates TLR2 signaling (Fig. 6), and (v) the cytotoxic activity can be reproduced by a purified BLP (murein lipoprotein) (data not shown) and two synthetic lipopeptides (Fig. 3).
There is likely to be a high degree of heterogeneity among the BLP present in S. flexneri EP. E. coli is genetically very similar to Shigella spp. and contains at least 20 putative BLP (34). In fact, we found that when EP was resolved by SDS-PAGE, the cytotoxic activity migrated over a broad MW range (Fig. 5C). This suggests that numerous BLP of various MW are responsible for the cytotoxic activity in EP. Additional diversity is likely generated by variability among the three acyl chains of the amino-terminal, lipid-modified cysteine residue (4, 34). Mass spectrometry was used to analyze HPLC fractions containing the cytotoxic activity from S. flexneri EP and phenol extracts of bacterial supernatants (data not shown). Unfortunately, we were unable to consistently detect single mass species. This is likely due to the cumulative heterogeneity among the lipid and protein components of S. flexneri BLP. We conclude that the cytotoxic activity in S. flexneri EP and culture supernatants is due to a mixture of BLP.
It has recently been shown that repurification of LPS from preparations contaminated with EP eliminates its ability to activate TLR2 (10, 29). Our data support this finding and extend this observation by showing that the TLR2-stimulatory properties of endotoxin can be quantitatively isolated in the EP fraction (Fig. 6A). Furthermore, HPLC analysis of EP shows that the TLR2-activating component copurifies with a cytotoxic activity likely to be BLP.
BLP have been previously purified from bacteria using macrophage stimulation assays (18, 31). However, in each case the initial source of activity was bacterial lysates. To our knowledge, the data presented here represent the first purification of a BLP immunomodulatory activity from bacterial culture supernatants. In gram-negative bacteria, BLP localize to the periplasmic side of either the inner or the outer membrane (34, 35). With this topology, it was previously unclear whether macrophages actually have access to the BLP of gram-negative bacteria. Our data indicate that BLP are recognized by macrophages in a native form released from the bacteria into culture supernatants.
It has been shown that macrophages infected with S. flexneri undergo cell death through a pathway dependent on the
secreted virulence factor, IpaB (6). We suggest
that the release of BLP is a second mechanism by which S. flexneri engages the host apoptotic machinery. We propose
the following model for the pathogenesis of shigellosis: (i)
translocation of S. flexneri from the lumen of the
intestine into the GALT by M cells; (ii) infection of subepithelial macrophages; (iii) induction of rapid macrophage apoptosis by IpaB with concomitant release of interleukin-1
, which initiates an
acute inflammatory response; (iv) destruction of the follicular associated epithelium, allowing the invasion of more S. flexneri; (v) exposure of cells in the GALT to BLP released from
both luminal and invading bacteria; and (vi) the induction of a
widespread pattern of cell death in the lymphoid follicles by BLP
through TLR2. In addition to inducing cell death, BLP would stimulate the production of proinflammatory cytokines and thus further aggravate the inflammation. Mitigation of the host response to BLP might alleviate the tissue destruction and symptoms of shigellosis. Moreover,
since all bacteria produce BLP, the results presented here have
implications for how the immune system recognizes and responds to
pathogens and suggests new avenues for therapeutic exploration.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jerrold Weiss, Tim Sellati, Yvette Weinrauch, and Kol Zarember for technical advice and assistance with the work presented in the manuscript. We also thank Gary Klimpel for providing the E. coli murein lipoprotein.
This work was supported by grants from the NIAID (AI 37720 to A.Z. and AI-38894 to J.D.R.). A.O.A was supported by a grant from the Life and Health Insurance Fund.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Skirball Institute, NYU School of Medicine, 540 First Ave., New York, NY 10016. Phone: (212) 263-7058. Fax: (212) 263-5711. E-mail: zychlins{at}saturn.med.nyu.edu.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aliprantis, A. O.,
R. B. Yang,
M. R. Mark,
S. Suggett,
B. Devaux,
J. D. Radolf,
G. R. Klimpel,
P. Godowski, and A. Zychlinsky.
1999.
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.
Science
285:736-739 |
| 2. | Aliprantis, A. O., R. B. Yang, D. S. Weiss, P. Godowski, and A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19:3325-3336[CrossRef][Medline]. |
| 3. |
Baeuerle, P., and T. Henkel.
1994.
Function and activation of NF- B in the immune system.
Annu. Rev. Immunol.
12:141-179[Medline].
|
| 4. |
Belisle, J. T.,
M. E. Brandt,
J. D. Radolf, and M. V. Norgard.
1994.
Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins.
J. Bacteriol.
176:2151-2157 |
| 5. |
Brightbill, H. D.,
D. H. Libraty,
S. R. Krutzik,
J. T. Belisle,
M. Maitland,
M. V. Norgard,
S. E. Plevy,
S. T. Smale,
P. J. Brennan,
B. R. Bloom,
P. J. Godowski, and R. L. Modlin.
1999.
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Science
285:732-736 |
| 6. | Chen, Y., M. R. Smith, K. Thirumalai, and A. Zychlinsky. 1996. A bacterial invasin induces macrophage apoptosis by directly binding ICE. EMBO J. 15:3853-3860[Medline]. |
| 7. | Goldman, R. C., D. White, and L. Leive. 1981. Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111. J. Immunol. 127:1290-1294[Medline]. |
| 8. |
Henderson, B.,
S. Poole, and M. Wilson.
1996.
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.
Microbiol. Rev.
60:316-341 |
| 9. |
Hirschfeld, M.,
C. J. Kirschning,
R. Schwandner,
H. Wesche,
J. H. Weis,
R. M. Wooten, and J. J. Weis.
1999.
Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.
J. Immunol.
163:2382-2386 |
| 10. |
Hirschfeld, M.,
Y. Ma,
J. H. Weis,
S. N. Vogel, and J. J. Weis.
2000.
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.
J. Immunol.
165:618-622 |
| 11. | Hoekstra, D., J. W. van der Laan, L. de Leij, and B. Witholt. 1976. Release of outer membrane fragments from normally growing Escherichia coli. Biochim. Biophys. Acta 455:889-899[Medline]. |
| 12. | Hoffmann, P., S. Heinle, U. F. Schade, H. Loppnow, A. J. Ulmer, H. D. Flad, G. Jung, and W. G. Bessler. 1988. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 177:158-170[Medline]. |
| 13. | Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W. H. O. 77:651-666[Medline]. |
| 14. |
Lien, E.,
T. J. Sellati,
A. Yoshimura,
T. H. Flo,
G. Rawadi,
R. W. Finberg,
J. D. Carroll,
T. Espevik,
R. R. Ingalls,
J. D. Radolf, and D. T. Golenbock.
1999.
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.
J. Biol. Chem.
274:33419-33425 |
| 15. | Manthey, C. L., P. Y. Perera, B. E. Henricson, T. A. Hamilton, N. Qureshi, and S. N. Vogel. 1994. Endotoxin-induced early gene expression in C3H/HeJ (Lpsd) macrophages. J. Immunol. 153:2653-2663[Abstract]. |
| 16. | Maurelli, A. T., and P. J. Sansonetti. 1988. Genetic determinants of Shigella pathogenicity. Annu. Rev. Microbiol. 42:127-150[Medline]. |
| 17. | Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818[CrossRef][Medline]. |
| 18. |
Muhlradt, P. F.,
M. Kiess,
H. Meyer,
R. Sussmuth, and G. Jung.
1997.
Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
J. Exp. Med.
185:1951-1958 |
| 19. |
Muhlradt, P. F.,
M. Kiess,
H. Meyer,
R. Sussmuth, and G. Jung.
1998.
Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
Infect. Immun.
66:4804-4810 |
| 20. | Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J. Immunol. 147:1968-1974[Abstract]. |
| 21. | Rothfield, L., and M. Pearlman-Kothencz. 1969. Synthesis and assembly of bacterial membrane components. A lipopolysaccharide-phospholipid-protein complex excreted by living bacteria. J. Mol. Biol. 44:477-492[CrossRef][Medline]. |
| 22. | Sansonetti, P. I. 1999. Shigella plays dangerous games. ASM News 65:611-617. |
| 23. | Sansonetti, P. J., J. Arondel, R. Cantey, M. C. Prevost, and M. Huerre. 1996. Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect. Immun. 64:2752-2764[Abstract]. |
| 24. |
Sansonetti, P. J.,
D. J. Kopecko, and S. B. Formal.
1981.
Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence.
Infect. Immun.
34:75-83 |
| 25. |
Sellati, T. J.,
D. A. Bouis,
R. L. Kitchens,
R. P. Darveau,
J. Pugin,
R. J. Ulevitch,
S. C. Gangloff,
S. M. Goyert,
M. V. Norgard, and J. D. Radolf.
1998.
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide.
J. Immunol.
160:5455-5464 |
| 26. | Sellati, T. J., M. J. Burns, M. A. Ficazzola, and M. B. Furie. 1995. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63:4439-4447[Abstract]. |
| 27. | Staub, A. M. 1965. Bacterial lipido-proteino-polysaccharides ('O' somatic antigens) extraction with trichloroacetic acid, vol. 5. Academic Press, New York, N.Y. |
| 28. |
Sultzer, B. M., and G. W. Goodman.
1976.
Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes.
J. Exp. Med.
144:821-827 |
| 29. |
Tapping, R. I.,
S. Akashi,
K. Miyake,
P. J. Godowski, and P. S. Tobias.
2000.
Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.
J. Immunol.
165:5780-5787 |
| 30. | Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:19-22[CrossRef][Medline]. |
| 31. | Vidal, V., I. G. Scragg, S. J. Cutler, K. A. Rockett, D. Fekade, D. A. Warrell, D. J. Wright, and D. Kwiatkowski. 1998. Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nat. Med. 4:1416-1420[CrossRef][Medline]. |
| 32. | Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure, vol. 5. Academic Press, New York, N.Y. |
| 33. |
Wooten, R. M.,
T. B. Morrison,
J. H. Weis,
S. D. Wright,
R. Thieringer, and J. J. Weis.
1998.
The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi.
J. Immunol.
160:5485-5492 |
| 34. | Wu, H. 1996. Biosynthesis of lipoproteins, p. 1005-1014. In F. C. Neidhardt, et al. (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 35. | Yakushi, T., K. Masuda, S. Narita, S. Matsuyama, and H. Tokuda. 2000. A new ABC transporter mediating the detachment of lipid-modified proteins from membranes. Nat. Cell Biol. 2:212-218[CrossRef][Medline]. |
| 36. | Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284-288[CrossRef][Medline]. |
| 37. | Zychlinsky, A., B. Kenny, R. Ménard, M. C. Prévost, I. B. Holland, and P. J. Sansonetti. 1994. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 11:619-627[Medline]. |
| 38. | Zychlinsky, A., M. C. Prévost, and P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-168[CrossRef][Medline]. |
| 39. | Zychlinsky, A., and P. Sansonetti. 1997. Perspectives series: host/pathogen interactions. apoptosis in bacterial pathogenesis. J. Clin. Investig. 100:493-495[Medline]. |
| 40. | Zychlinsky, A., K. Thirumalai, J. Arondel, J. R. Cantey, A. Aliprantis, and P. J. Sansonetti. 1996. In vivo apoptosis in Shigella flexneri infections. Infect. Immun. 64:5357-5365[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|